Marzia Marciello

Prof. Dr. Marzia Marciello

Nanobiotechnology for Life Science Lab (NANOBIOTECH4LS), Department of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Compliutense University of Madrid (UCM), Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2014 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
DSDavid Serantes
David Serantes
Konstantinos SimeonidisKonstantinos Simeonidis
Konstantinos Simeonidis
MAMAKIS ANGELAKERIS
MAKIS ANGELAKERIS
OCOksana Chubikalo-Fesenko
Oksana Chubikalo-Fesenko
Marzia MarcielloMarzia Marciello
Marzia Marciello
Carlos Martinez-BoubetaCarlos Martinez-Boubeta
Carlos Martinez-Boubeta

26 January 2016 in Langmuir
Verified
Journal Article
Closed access
DCDiego Coral
Diego Coral
PZPedro Mendoza Zélis
Pedro Mendoza Zélis
Marzia MarcielloMarzia Marciello
Marzia Marciello
MMMaría del Puerto Morales
María del Puerto Morales
ACAldo Craievich
Aldo Craievich
MRMarcela B. Fernández van Raap
Marcela B. Fernández van Raap

10 June 2013 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
Marco FiliceMarco Filice
Marco Filice
Marzia MarcielloMarzia Marciello
Marzia Marciello
MMMaria del Puerto Morales
Maria del Puerto Morales
Jose M PalomoJose M Palomo
Jose M Palomo
The straightforward synthesis of novel enzyme–metalNP nanobiohybrids in aqueous medium was developed. These new nanobiohybrids were excellent multivalent catalysts combining both activities in various sets of synthetic reactions even at ultra-low concentrations (ppb amount).

3 June 2014 in Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
SKSusanne Kossatz
Susanne Kossatz
RLRobert Ludwig
Robert Ludwig
HDHeidi Dähring
Heidi Dähring
VEVolker Ettelt
Volker Ettelt
GRGabriella Rimkus
Gabriella Rimkus
IHIngrid Hilger
Ingrid Hilger
Purpose Tumor cells can be effectively inactivated by heating mediated by magnetic nanoparticles. However, optimized nanomaterials to supply thermal stress inside the tumor remain to be identified. The present study investigates the therapeutic effects of magnetic hyperthermia induced by superparamagnetic iron oxide nanoparticles on breast (MDA-MB-231) and pancreatic cancer (BxPC-3) xenografts in mice in vivo. Methods Superparamagnetic iron oxide nanoparticles, synthesized either via an aqueous (MF66; average core size 12 nm) or an organic route (OD15; average core size 15 nm) are analyzed in terms of their specific absorption rate (SAR), cell uptake and their effectivity in in vivo hyperthermia treatment. Results Exceptionally high SAR values ranging from 658 ± 53 W*gFe −1 for OD15 up to 900 ± 22 W*gFe −1 for MF66 were determined in an alternating magnetic field (AMF, H = 15.4 kA*m−1 (19 mT), f = 435 kHz). Conversion of SAR values into system-independent intrinsic loss power (ILP, 6.4 ± 0.5 nH*m2*kg−1 (OD15) and 8.7 ± 0.2 nH*m2*kg−1 (MF66)) confirmed the markedly high heating potential compared to recently published data. Magnetic hyperthermia after intratumoral nanoparticle injection results in dramatically reduced tumor volume in both cancer models, although the applied temperature dosages measured as CEM43T90 (cumulative equivalent minutes at 43°C) are only between 1 and 24 min. Histological analysis of magnetic hyperthermia treated tumor tissue exhibit alterations in cell viability (apoptosis and necrosis) and show a decreased cell proliferation. Conclusions Concluding, the studied magnetic nanoparticles lead to extensive cell death in human tumor xenografts and are considered suitable platforms for future hyperthermic studies.

6 December 2016 in Scientific Reports
Verified
Journal Article
Open access
Konstantinos SimeonidisKonstantinos Simeonidis
Konstantinos Simeonidis
MMM. Puerto Morales
M. Puerto Morales
Marzia MarcielloMarzia Marciello
Marzia Marciello
MAMAKIS ANGELAKERIS
MAKIS ANGELAKERIS
Patricia De La PresaPatricia De La Presa
Patricia De La Presa
DSDavid Serantes
David Serantes
Promising advances in nanomedicine such as magnetic hyperthermia rely on a precise control of the nanoparticle performance in the cellular environment. This constitutes a huge research challenge due to difficulties for achieving a remote control within the human body. Here we report on the significant double role of the shape of ellipsoidal magnetic nanoparticles (nanorods) subjected to an external AC magnetic field: first, the heat release is increased due to the additional shape anisotropy; second, the rods dynamically reorientate in the orthogonal direction to the AC field direction. Importantly, the heating performance and the directional orientation occur in synergy and can be easily controlled by changing the AC field treatment duration, thus opening the pathway to combined hyperthermic/mechanical nanoactuators for biomedicine. Preliminary studies demonstrate the high accumulation of nanorods into HeLa cells whereas viability analysis supports their low toxicity and the absence of apoptotic or necrotic cell death after 24 or 48 h of incubation.

4 August 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
Lei WangLei Wang
Lei Wang
Marzia MarcielloMarzia Marciello
Marzia Marciello
MEMiquel Estévez-Gay
Miquel Estévez-Gay
PRPaul E. D. Soto Rodriguez
Paul E. D. Soto Rodriguez
YMYurena Luengo Morato
Yurena Luengo Morato
SSSamuel Sánchez
Samuel Sánchez